|
1
|
Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors.
|
J Med Chem
|
2010
|
2.28
|
|
2
|
Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate.
|
J Biomed Mater Res A
|
2012
|
0.96
|
|
3
|
Increasing strut porosity in silicate-substituted calcium-phosphate bone graft substitutes enhances osteogenesis.
|
J Biomed Mater Res B Appl Biomater
|
2011
|
0.86
|
|
4
|
Studies of benzothiophene template as potent factor IXa (FIXa) inhibitors in thrombosis.
|
J Med Chem
|
2010
|
0.78
|
|
5
|
Pharmacodynamic and efficacy profile of TGN 255, a novel direct thrombin inhibitor, in canine cardiopulmonary bypass and simulated mitral valve repair.
|
J Extra Corpor Technol
|
2008
|
0.75
|